Companies: 10,795·Total market cap: $144.5T
ALK-Abelló A/S

ALK-Abelló A/S

AKBLFOTCHealthcare● Active
$31.35
$-7.54(-19.39%)
Market Cap$6.3B
P/E Ratio
52W High$38.89
52W Low$26.99

ALK-Abelló A/S (AKBLF) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · AKBLF · as of 2026-06-09

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$6.30B$5.54B$4.82B$4.51B$3.92B
Cost of Revenue$2.15B$1.99B$1.79B$1.72B$1.52B
Gross Profit$4.15B$3.55B$3.04B$2.79B$2.40B
Gross Margin %(computed)65.87%64.15%62.91%61.87%61.34%
Operating Expenses
R&D Expenses$0.59B$0.53B$0.62B$0.67B$0.63B
G&A Expenses$0.00B$0.37B$0.33B$0.28B$0.24B
Total Operating Expenses$2.49B$2.46B$2.37B$2.32B$2.10B
Operating Income$1.66B$1.09B$0.67B$0.47B$0.29B
Operating Margin %(computed)26.35%19.70%13.81%10.42%7.46%
Interest Income$0.03B$0.06B$0.01B$0.00B$0.00B
Interest Expense$0.02B$0.07B$0.02B$0.02B$0.02B
Income Before Tax$1.63B$1.06B$0.65B$0.45B$0.28B
Income Tax Expense$0.44B$0.24B$0.16B$0.11B$0.06B
Net Income$1.19B$0.81B$0.49B$0.34B$0.22B
Net Margin %(computed)18.96%14.72%10.07%7.43%5.59%
Per Share & EBITDA
EPS (Basic)$5.41$3.68$2.20$1.52$1.00
Wtd Avg Shares0.22B0.22B0.22B0.22B0.22B
EBITDA$1.98B$1.39B$0.91B$0.71B$0.54B
EBITDA Margin %(computed)31.38%25.18%18.93%15.72%13.89%

Data source: Financial Modeling Prep · Last updated: 2026-06-09 · DKK · B

Explore more ALK-Abelló A/S data

About ALK-Abelló A/S (AKBLF) Income Statement

ALK-Abelló A/S (AKBLF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, AKBLF reported revenue of $6.30B, gross profit of $4.15B (gross margin 65.87%), and net income of $1.19B — a net profit margin of 18.96%.

Frequently asked questions

AKBLF · 4 questions

ALK-Abelló A/S (AKBLF) reported revenue of $6.30B for 2025, up 13.7% year-over-year.

AKBLF revenueAKBLF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09